Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
June 24, 2019
In this note, we summarize the changing context and its relevance for Gavi, exploring the specific issues relevant to transitioning countries, never-eligible MICs, and countries dealing with complex emergencies or large-scale protracted displacement. We then offer four recommendations to increase Ga...
CGD NOTES
June 24, 2019
With a vision of “creating equal access to new and underused vaccines,” Gavi set several coverage-specific targets for 2020 as part of its Phase IV strategy, including the immunization of an additional 300 million children, increased pentavalent 3 and measles-containing vaccine (MCV) 1 c...
Blog Post
May 15, 2019
In March, our team at the Center for Global Development and Office of Health Economics posted a consultation draft of a policy proposal for a Market-Driven, Value-Based Advanced Commitment (MVAC). The MVAC is a new mechanism that puts middle-income country governments in the driver’s...
Blog Post
March 20, 2019
The Board of Gavi, The Vaccine Alliance, will retreat next week to discuss a new strategy and replenishment. My colleagues and I have put together a preliminary set of six short notes that examine different dimensions of Gavi’s work and make recommendations for ways to address identified ...
Blog Post
February 07, 2019
In December 2018, the Gavi Alliance hosted a mid-term review to assess progress towards its core purpose: “reach every child everywhere with vaccines against preventable diseases.” The good news is that there’s been advances on new vaccine introductions, and an estimated 65 million...
Oct
29
2018
10:30—12:00 PM
October 16, 2018
More than two years after we saw the end of a deadly Ebola epidemic that claimed the lives of over 11,000 people and devastated populations in West Africa, new mechanisms have been pursued to strengthen preparedness efforts, stimulate innovation for new vaccines and therapies, and develop rapid and ...